SELECTIVE NATURAL κ OPIOID AND CANNABINOID RECEPTOR AGONISTS WITH A POTENTIAL ROLE IN THE TREATMENT OF GASTROINTESTINAL DYSFUNCTION

被引:18
|
作者
Fichna, Jakub [1 ]
Schicho, Rudolf [2 ]
Janecko, Anna [1 ]
Zjawiony, Jordan K. [3 ]
Storr, Martin [2 ]
机构
[1] Med Univ Lodz, Fac Med, Dept Biomol Chem, Lodz, Poland
[2] Univ Calgary, Dept Med, Div Gastroenterol, Calgary, AB T2N 4N1, Canada
[3] Univ Mississippi, Sch Pharm, Dept Pharmacognosy, University, MS 38677 USA
关键词
SALVINORIN-A ANALOGS; IRRITABLE-BOWEL-SYNDROME; PLANT-DERIVED HALLUCINOGEN; HERB SALVIA-DIVINORUM; NEOCLERODANE DITERPENES; IN-VITRO; ENDOCANNABINOID SYSTEM; INDUCED HYPERMOTILITY; COLONIC INFLAMMATION; INDUCED INHIBITION;
D O I
10.1358/dnp.2009.22.7.1400219
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Salvinorin A is the major active ingredient of Salvia divinorum, a plant used by the Mazatec Indians of Mexico for spiritual and medical purposes. Different preparations from S. divinorum are also used in traditional heating practices to treat gastrointestinal disorders, including diarrhea. The recent extensive research on salvinorin A and other neoclerodane diterpenoids derived from S. divinorum resulted in a large number of reports describing their isolation, synthesis and structure-activity relationship. This review summarizes the present knowledge on salvinorin A and its analogues, with a focus on the effects on gastrointestinal tissues. We furthermore discuss structural changes in salvinorin A that may facilitate future use of its derivatives in human disease.
引用
收藏
页码:383 / 392
页数:10
相关论文
共 50 条
  • [31] In vitro and in vivo efficacy of a potent opioid receptor agonist, biphalin, compared to subtype-selective opioid receptor agonists for stroke treatment
    Yang, Li
    Islam, Mohammad R.
    Karamyan, Vardan T.
    Abbruscato, Thomas J.
    BRAIN RESEARCH, 2015, 1609 : 1 - 11
  • [32] Development of functionally selective agonists at the kappa opioid receptor (KOR)
    Lovell, Kimberly M.
    Zhou, Lei
    Frankowski, Kevin J.
    Slauson, Stephen R.
    Streicher, John M.
    Phillips, Angela
    Prisinzano, Thomas E.
    Aube, Jeffrey
    Bohn, Laura M.
    FASEB JOURNAL, 2013, 27
  • [33] Chemotype-selective Modes of Action of κ-Opioid Receptor Agonists
    Vardy, Eyal
    Mosier, Philip D.
    Frankowski, Kevin J.
    Wu, Huixian
    Katritch, Vsevolod
    Westkaemper, Richard B.
    Aube, Jeffrey
    Stevens, Raymond C.
    Roth, Bryan L.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2013, 288 (48) : 34470 - 34483
  • [34] Cannabinoid receptor activation potential of the next generation, generic ban evading OXIZID synthetic cannabinoid receptor agonists
    Deventer, Marie H.
    Van Uytfanghe, Katleen
    Vinckier, Inge M. J.
    Reniero, Fabiano
    Guillou, Claude
    Stove, Christophe P.
    DRUG TESTING AND ANALYSIS, 2022, 14 (09) : 1565 - 1575
  • [35] Structure, dynamics, and binding modes of selective μ-agonists on the μ-opioid receptor
    Subramanian, G
    Paterlini, MG
    Ferguson, DM
    BIOPHYSICAL JOURNAL, 1999, 76 (01) : A112 - A112
  • [36] μ-Opioid receptor-knockout mice:: the role of μ-opioid receptor in gastrointestinal transit
    Roy, S
    Liu, HC
    Loh, HH
    MOLECULAR BRAIN RESEARCH, 1998, 56 (1-2): : 281 - 283
  • [37] Characterization of Subtype Selective Cannabinoid CB2 Receptor Agonists as Potential Anti-Inflammatory Agents
    Tang, Yaliang
    Wolk, Barbara
    Nolan, Ryan
    Scott, Caitlin E.
    Kendall, Debra A.
    PHARMACEUTICALS, 2021, 14 (04)
  • [38] ANTINOCICEPTION INDUCED BY INTRATHECAL COADMINISTRATION OF SELECTIVE ADENOSINE RECEPTOR AND SELECTIVE OPIOID RECEPTOR AGONISTS IN MICE
    DELANDER, GE
    KEIL, GJ
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1994, 268 (02): : 943 - 951
  • [39] Novel peripheral dual δ/μ opioid receptor agonists for gastrointestinal disorders.
    Kavash, RW
    Breslin, HJ
    Cai, CZ
    Diamond, CJ
    Coutinho, SV
    Wade, PR
    McKenney, SL
    Zhang, SP
    Wallace, NH
    Schneider, CR
    Hornby, PJ
    He, W
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 227 : U58 - U58
  • [40] Cannabinoid CB1 receptor agonists produce cerebellar dysfunction in mice
    Patel, S
    Hillard, CJ
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2001, 297 (02): : 629 - 637